Predicting Clinical Drug Combination Efficacy Using In Vitro Monotherapy Data
AL Ling - 2019 - search.proquest.com
Drug combinations are a cornerstone of cancer therapy, but the vast number of possible
drug combinations makes it infeasible to screen them all experimentally when identifying …
drug combinations makes it infeasible to screen them all experimentally when identifying …
[PDF][PDF] Linee guida NEOPLASIE DELLO STOMACO E DELLA GIUNZIONE ESOFAGO-GASTRICA
ND STOMACO - media.aiom.it
Le raccomandazioni cliniche fondamentali vengono presentate in tabelle e vengono
corredate dalla qualità delle evidenze a supporto e dalla forza della raccomandazione Nel …
corredate dalla qualità delle evidenze a supporto e dalla forza della raccomandazione Nel …
Therapiekonzepte in der kurativen Behandlung des Magenkarzinoms
TO Götze, SE Al-Batran - TumorDiagnostik & Therapie, 2017 - thieme-connect.com
Das Magenkarzinom ist mit jährlich ca. 952 000 neuen Fällen die fünfthäufigste Krebsart
weltweit und steht an dritter Stelle der krebsbedingten Todesursachen [1]. Danach …
weltweit und steht an dritter Stelle der krebsbedingten Todesursachen [1]. Danach …
Perioperative Systemtherapie bei Magen-und Kardiakarzinom
C Treese, S Daum - Moderne Chirurgie des Magen-und Kardiakarzinoms, 2017 - Springer
Erste multimodale Therapieansätze haben bereits in den 1990er-Jahren Einzug in die
Behandlung des lokal fortgeschrittenen Magenkarzinoms gehalten. Neben der Optimierung …
Behandlung des lokal fortgeschrittenen Magenkarzinoms gehalten. Neben der Optimierung …
[HTML][HTML] Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel–Cisplatin–Fluorouracil (DCF) versus CRT plus Fluorouracil–Folinic Acid (FUFA) in Stage III …
Methods: Patients with a diagnosis of stage III gastric cancer treated with adjuvant therapy
after curative resection were analyzed. Patients' disease characteristics and impacts of the …
after curative resection were analyzed. Patients' disease characteristics and impacts of the …
Comparison of Clinical Effect Between mFOLFOX6 and FOLFIRI Regimen as Alternately First-and Second-line Therapy on Advanced Gastric Cancer Patients
T Gangling, C Boran, C Xiaoqiu, S Donglan… - Cancer Research on …, 2017 - zlfzyj.com
Objective To observe and compare the efficacy and adverse reactions between mFOLFOX6
and FOLFIRI regimen as alternately first-and second-line chemotherapy on the patients with …
and FOLFIRI regimen as alternately first-and second-line chemotherapy on the patients with …
Gastric Cancer Management: East vs. West?
SR Park, YK Kang - Multidisciplinary Management Of …, 2016 - books.google.com
Almost 1 million people are newly diagnosed with gastric cancer annually, and about 75% of
these die of the disease, making gastric cancer the second leading cause of cancer death …
these die of the disease, making gastric cancer the second leading cause of cancer death …
Multimodal therapy of localized gastric cancer
A Stein, D Arnold, SE Al-Batran - Der Onkologe, 2016 - Springer
Zusammenfassung Hintergrund Die lokalisierten Adenokarzinome des gastroösophagealen
Übergangs und des Magens weisen nach alleiniger Operation mit einem …
Übergangs und des Magens weisen nach alleiniger Operation mit einem …
Multimodale Therapie des lokalisierten Magenkarzinoms
A Stein, D Arnold, SE Al-Batran - Die Onkologie, 2016 - search.proquest.com
Multimodale Therapie des lokalisierten Magenkarzinoms Page 1 Leitthema Onkologe 2016 ·
22:392–399 DOI 10.1007/s00761-016-0031-7 Online publiziert: 9. Mai 2016 © Springer-Verlag …
22:392–399 DOI 10.1007/s00761-016-0031-7 Online publiziert: 9. Mai 2016 © Springer-Verlag …
Современное состояние комбинированного лечения рака желудка: достижения, перспективы
ВЮ Скоропад - Поволжский онкологический вестник, 2016 - elibrary.ru
Представлены принятые в различных регионах мира стандарты комбинированного
лечения больных местно-распространенным раком желудка, и результаты крупных …
лечения больных местно-распространенным раком желудка, и результаты крупных …